Swisher Daniel N JR's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Aug 9, 2022
- Accession no.
- 0000899243-22-028147
- Filed
- Aug 9, 2022
- Trade date
- Aug 8, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $435.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Swisher Daniel N JRCIK 0001323113 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | MOption exerciseAcquired | +20,000 | $6.55 | +$131,000 | 20,000 | Direct | |
| Aug 8, 2022 | Common Stock | FTax withholdingDisposed | −4,615 | $28.39 | −$131,019.85 | 15,385 | Direct | |
| Aug 8, 2022 | Common Stock | SSaleDisposed | −15,385 | $28.32F2 | −$435,703.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 7,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.30 to $28.38 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from Issuer upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
The power of attorney under which this form was signed is on file with the Commission.